Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Impact of DARC, GSDMA and CXCL2 polymorphisms on induction toxicity in children with acute lymphoblastic leukemia: A complementary study.

Gatineau-Sailliant S, Glisovic S, Gagné V, Laverdière C, Leclerc JM, Silverman LB, Sinnett D, Krajinovic M, Pastore Y.

Leuk Res. 2019 Sep 29;86:106228. doi: 10.1016/j.leukres.2019.106228. [Epub ahead of print] No abstract available.

PMID:
31590117
2.

Physical Activity and Sedentary Behaviors in Childhood Acute Lymphoblastic Leukemia Survivors.

Lemay V, Caru M, Samoilenko M, Drouin S, Mathieu ME, Bertout L, Lefebvre G, Raboisson MJ, Krajinovic M, Laverdière C, Andelfinger G, Sinnett D, Curnier D.

J Pediatr Hematol Oncol. 2019 Sep 19. doi: 10.1097/MPH.0000000000001594. [Epub ahead of print]

PMID:
31568179
3.

Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.

Pincez T, Landry JR, Roussy M, Jouan L, Bilodeau M, Laramée L, Couture F, Sinnett D, Gendron P, Hébert J, Oligny L, Rouette A, Tran TH, Wilhelm BT, Bittencourt H, Cellot S.

Genes Chromosomes Cancer. 2019 Sep 12. doi: 10.1002/gcc.22808. [Epub ahead of print]

PMID:
31515871
4.

Inherited genetic susceptibility of acute lymphoblastic leukemia in Down syndrome.

Brown AL, de Smith AJ, Gant VU, Yang W, Scheurer ME, Walsh KM, Chernus JM, Kallsen NA, Peyton SA, Davies GE, Ehli EA, Winick N, Heerema NA, Carroll AJ, Borowitz MJ, Wood BL, Carroll WL, Raetz EA, Feingold E, Devidas M, Barcellos LF, Hansen HM, Morimoto L, Kang AY, Smirnov I, Healy J, Laverdière C, Sinnett D, Taub JW, Birch JM, Thompson P, Spector LG, Pombo-de-Oliveira MS, DeWan AT, Mullighan CG, Hunger SP, Pui CH, Loh ML MD, Zwick ME, Metayer C, Ma X, Mueller BA, Sherman SL, Wiemels JL, Relling MV, Yang JJ, Lupo PJ, Rabin KR.

Blood. 2019 Jul 26. pii: blood.2018890764. doi: 10.1182/blood.2018890764. [Epub ahead of print]

PMID:
31350265
5.

Visual short-term memory activation patterns in adult survivors of childhood acute lymphoblastic leukemia.

Boulet-Craig A, Robaey P, Barlaam F, Laniel J, Oswald V, Jerbi K, Sultan S, Affret-Bertout L, Drouin S, Krajinovic M, Laverdière C, Sinnett D, Jolicoeur P, Lippé S.

Cancer. 2019 Oct 15;125(20):3639-3648. doi: 10.1002/cncr.32374. Epub 2019 Jul 16.

PMID:
31310324
6.

Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome.

de Smith AJ, Walsh KM, Morimoto LM, Francis SS, Hansen HM, Jeon S, Gonseth S, Chen M, Sun H, Luna-Fineman S, Antillón F, Girón V, Kang AY, Smirnov I, Shao X, Whitehead TP, Barcellos LF, Jolly KW, Healy J, Laverdière C, Sinnett D, Taub JW, Birch JM, Thompson PD, Pombo-de-Oliveira MS, Spector LG, DeWan AT, Mueller BA, Chiang C, Metayer C, Ma X, Wiemels JL.

Leukemia. 2019 Jul 11. doi: 10.1038/s41375-019-0514-9. [Epub ahead of print] No abstract available.

PMID:
31296947
7.

Childhood Acute Lymphoblastic Leukemia Survivors Have a Substantially Lower Cardiorespiratory Fitness Level than Healthy Canadians Despite a Clinically Equivalent Level of Physical Activity.

Caru M, Samoilenko M, Drouin S, Lemay V, Kern L, Romo L, Bertout L, Lefebvre G, Andelfinger G, Krajinovic M, Laverdiere C, Sinnett D, Curnier D.

J Adolesc Young Adult Oncol. 2019 Jul 9. doi: 10.1089/jayao.2019.0024. [Epub ahead of print]

PMID:
31287753
8.

Environmental, health, wellbeing, social and equity effects of urban green space interventions: A meta-narrative evidence synthesis.

Hunter RF, Cleland C, Cleary A, Droomers M, Wheeler BW, Sinnett D, Nieuwenhuijsen MJ, Braubach M.

Environ Int. 2019 Sep;130:104923. doi: 10.1016/j.envint.2019.104923. Epub 2019 Jun 19. Review.

9.

Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.

Da Costa EM, Armaos G, McInnes G, Beaudry A, Moquin-Beaudry G, Bertrand-Lehouillier V, Caron M, Richer C, St-Onge P, Johnson JR, Krogan N, Sai Y, Downey M, Rafei M, Boileau M, Eppert K, Flores-Díaz E, Haman A, Hoang T, Sinnett D, Beauséjour C, McGraw S, Raynal NJ.

J Exp Clin Cancer Res. 2019 Jun 13;38(1):251. doi: 10.1186/s13046-019-1242-8.

10.

Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.

Petrykey K, Lippé S, Robaey P, Sultan S, Laniel J, Drouin S, Bertout L, Beaulieu P, St-Onge P, Boulet-Craig A, Rezgui A, Yasui Y, Sapkota Y, Krull KR, Hudson MM, Laverdière C, Sinnett D, Krajinovic M.

PLoS One. 2019 Jun 10;14(6):e0217314. doi: 10.1371/journal.pone.0217314. eCollection 2019.

11.

Identification of genetic variants associated with skeletal muscle function deficit in childhood acute lymphoblastic leukemia survivors.

Nadeau G, Ouimet-Grennan E, Aaron M, Drouin S, Bertout L, Shalmiev A, Beaulieu P, St-Onge P, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M.

Pharmgenomics Pers Med. 2019 Apr 11;12:33-45. doi: 10.2147/PGPM.S192924. eCollection 2019.

12.

Identification of genetic association between cardiorespiratory fitness and the trainability genes in childhood acute lymphoblastic leukemia survivors.

Caru M, Petrykey K, Drouin S, Beaulieu P, St-Onge P, Lemay V, Bertout L, Laverdiere C, Andelfinger G, Krajinovic M, Sinnett D, Curnier D.

BMC Cancer. 2019 May 14;19(1):443. doi: 10.1186/s12885-019-5651-z.

13.

A Bayesian multivariate latent t-regression model for assessing the association between corticosteroid and cranial radiation exposures and cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia: a PETALE study.

Caubet Fernandez M, Drouin S, Samoilenko M, Morel S, Krajinovic M, Laverdière C, Sinnett D, Levy E, Marcil V, Lefebvre G.

BMC Med Res Methodol. 2019 May 14;19(1):100. doi: 10.1186/s12874-019-0725-9.

14.

Is there a relationship between vitamin D nutritional status and metabolic syndrome in childhood acute lymphoblastic leukemia survivors? A PETALE study.

Delvin E, Marcil V, Alos N, Laverdière C, Sinnett D, Krajinovic M, Bélanger V, Drouin S, Nyalendo C, Levy E.

Clin Nutr ESPEN. 2019 Jun;31:28-32. doi: 10.1016/j.clnesp.2019.03.006. Epub 2019 Apr 2.

PMID:
31060831
15.

Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers.

Khater F, Vairy S, Langlois S, Dumoucel S, Sontag T, St-Onge P, Bittencourt H, Dal Soglio D, Champagne J, Duval M, Leclerc JM, Laverdiere C, Tran TH, Patey N, Ellezam B, Perreault S, Piché N, Samson Y, Teira P, Jabado N, Michon B, Brossard J, Marzouki M, Cellot S, Sinnett D.

JAMA Netw Open. 2019 Apr 5;2(4):e192906. doi: 10.1001/jamanetworkopen.2019.2906.

16.

Identification of a single-nucleotide polymorphism within CDH2 gene associated with bone morbidity in childhood acute lymphoblastic leukemia survivors.

Aaron M, Nadeau G, Ouimet-Grennan E, Drouin S, Bertout L, Beaulieu P, St-Onge P, Shalmiev A, Veilleux LN, Rauch F, Petrykey K, Laverdière C, Sinnett D, Alos N, Krajinovic M.

Pharmacogenomics. 2019 Apr;20(6):409-420. doi: 10.2217/pgs-2018-0169. Epub 2019 Apr 15.

PMID:
30983502
17.

miR-431-5p Knockdown Protects Against Angiotensin II-Induced Hypertension and Vascular Injury.

Huo KG, Richer C, Berillo O, Mahjoub N, Fraulob-Aquino JC, Barhoumi T, Ouerd S, Coelho SC, Sinnett D, Paradis P, Schiffrin EL.

Hypertension. 2019 May;73(5):1007-1017. doi: 10.1161/HYPERTENSIONAHA.119.12619.

PMID:
30929512
18.

Altered proteome of high-density lipoproteins from paediatric acute lymphoblastic leukemia survivors.

Fournier M, Bonneil E, Garofalo C, Grimard G, Laverdière C, Krajinovic M, Drouin S, Sinnett D, Marcil V, Levy E.

Sci Rep. 2019 Mar 12;9(1):4268. doi: 10.1038/s41598-019-40906-x.

19.

Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control.

Hamdi Y, Leclerc M, Dumont M, Dubois S, Tranchant M, Reimnitz G, Soucy P, Cassart P, Ouimet M, Sinnett D, Chaieb MLL, Simard J.

Genes (Basel). 2019 Feb 28;10(3). pii: E186. doi: 10.3390/genes10030186.

20.

Psychosocial Intervention Programs for Parents of Children with Cancer: A Systematic Review and Critical Comparison of Programs' Models and Development.

Ogez D, Péloquin K, Bertout L, Bourque CJ, Curnier D, Drouin S, Laverdière C, Marcil V, Ribeiro R, Callaci M, Rondeau E, Sinnett D, Sultan S.

J Clin Psychol Med Settings. 2019 Feb 26. doi: 10.1007/s10880-019-09612-8. [Epub ahead of print]

PMID:
30806900
21.

A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?

Marcil V, Levy E, Amre D, Bitton A, Sant'Anna AMGA, Szilagy A, Sinnett D, Seidman EG.

Inflamm Bowel Dis. 2019 Jul 17;25(8):1428-1441. doi: 10.1093/ibd/izy403.

PMID:
30793155
22.

Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.

Caru M, Corbin D, Périé D, Lemay V, Delfrate J, Drouin S, Bertout L, Krajinovic M, Laverdière C, Andelfinger G, Sinnett D, Curnier D.

Clin Res Cardiol. 2019 Sep;108(9):1000-1008. doi: 10.1007/s00392-019-01427-9. Epub 2019 Feb 18.

PMID:
30778669
23.

Definition and improvement of the concept and tools of a psychosocial intervention program for parents in pediatric oncology: a mixed-methods feasibility study conducted with parents and healthcare professionals.

Ogez D, Bourque CJ, Péloquin K, Ribeiro R, Bertout L, Curnier D, Drouin S, Laverdière C, Marcil V, Rondeau É, Sinnett D, Sultan S.

Pilot Feasibility Stud. 2019 Feb 6;5:20. doi: 10.1186/s40814-019-0407-8. eCollection 2019.

24.

Prevention of Long-term Adverse Health Outcomes With Cardiorespiratory Fitness and Physical Activity in Childhood Acute Lymphoblastic Leukemia Survivors.

Lemay V, Caru M, Samoilenko M, Drouin S, Alos N, Lefebvre G, Levy E, Lippé S, Marcil V, Sultan S, Bertout L, Krajinovic M, Laverdière C, Raboisson MJ, Sinnett D, Andelfinger G, Curnier D.

J Pediatr Hematol Oncol. 2019 Oct;41(7):e450-e458. doi: 10.1097/MPH.0000000000001426.

PMID:
30688830
25.

Recurrent somatic BRAF insertion (p.V504_R506dup): a tumor marker and a potential therapeutic target in pilocytic astrocytoma.

Khater F, Langlois S, Cassart P, Roy AM, Lajoie M, Healy J, Richer C, St-Onge P, Piché N, Perreault S, Cellot S, Marzouki M, Jabado N, Sinnett D.

Oncogene. 2019 Apr;38(16):2994-3002. doi: 10.1038/s41388-018-0623-3. Epub 2018 Dec 21.

26.

Very long intergenic non-coding RNA transcripts and expression profiles are associated to specific childhood acute lymphoblastic leukemia subtypes.

Caron M, St-Onge P, Drouin S, Richer C, Sontag T, Busche S, Bourque G, Pastinen T, Sinnett D.

PLoS One. 2018 Nov 15;13(11):e0207250. doi: 10.1371/journal.pone.0207250. eCollection 2018.

27.

TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw.

Gomes CC, Gayden T, Bajic A, Harraz OF, Pratt J, Nikbakht H, Bareke E, Diniz MG, Castro WH, St-Onge P, Sinnett D, Han H, Rivera B, Mikael LG, De Jay N, Kleinman CL, Valera ET, Bassenden AV, Berghuis AM, Majewski J, Nelson MT, Gomez RS, Jabado N.

Nat Commun. 2018 Nov 1;9(1):4572. doi: 10.1038/s41467-018-06690-4.

28.

Genome wide mapping of ETV6 binding sites in pre-B leukemic cells.

Neveu B, Caron M, Lagacé K, Richer C, Sinnett D.

Sci Rep. 2018 Oct 19;8(1):15526. doi: 10.1038/s41598-018-33947-1.

29.

SURVEY OF ARCTIC ALASKAN WILDLIFE FOR INFLUENZA A ANTIBODIES: LIMITED EVIDENCE FOR EXPOSURE OF MAMMALS.

Hemert CV, Spivey TJ, Uher-Koch BD, Atwood TC, Sinnett DR, Meixell BW, Hupp JW, Jiang K, Adams LG, Gustine DD, Ramey AM, Wan XF.

J Wildl Dis. 2019 Apr;55(2):387-398. doi: 10.7589/2018-05-128. Epub 2018 Oct 5.

PMID:
30289331
30.

Cancer-related effects on relationships, long-term psychological status and relationship satisfaction in couples whose child was treated for leukemia: A PETALE study.

Burns W, Péloquin K, Rondeau É, Drouin S, Bertout L, Lacoste-Julien A, Krajinovic M, Laverdière C, Sinnett D, Sultan S.

PLoS One. 2018 Sep 7;13(9):e0203435. doi: 10.1371/journal.pone.0203435. eCollection 2018.

31.

Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencing.

Abaji R, Ceppi F, Patel S, Gagné V, Xu CJ, Spinella JF, Colombini A, Parasole R, Buldini B, Basso G, Conter V, Cazzaniga G, Leclerc JM, Laverdière C, Sinnett D, Krajinovic M.

Pharmacogenomics. 2018 Oct;19(15):1181-1193. doi: 10.2217/pgs-2018-0093. Epub 2018 Sep 7.

PMID:
30191766
32.

Trametinib for progressive pediatric low-grade gliomas.

Kondyli M, Larouche V, Saint-Martin C, Ellezam B, Pouliot L, Sinnett D, Legault G, Crevier L, Weil A, Farmer JP, Jabado N, Perreault S.

J Neurooncol. 2018 Nov;140(2):435-444. doi: 10.1007/s11060-018-2971-9. Epub 2018 Aug 10.

PMID:
30097824
33.

Psychological risk in long-term survivors of childhood acute lymphoblastic leukemia and its association with functional health status: A PETALE cohort study.

Anestin AS, Lippé S, Robaey P, Bertout L, Drouin S, Krajinovic M, Michon B, Rondeau É, Samoilenko M, Laverdière C, Sinnett D, Sultan S.

Pediatr Blood Cancer. 2018 Nov;65(11):e27356. doi: 10.1002/pbc.27356. Epub 2018 Aug 7.

PMID:
30084222
34.

DIVERGT screening procedure predicts general cognitive functioning in adult long-term survivors of pediatric acute lymphoblastic leukemia: A PETALE study.

Boulet-Craig A, Robaey P, Laniel J, Bertout L, Drouin S, Krajinovic M, Laverdière C, Sinnett D, Sultan S, Lippé S.

Pediatr Blood Cancer. 2018 Sep;65(9):e27259. doi: 10.1002/pbc.27259. Epub 2018 May 24.

PMID:
29797640
35.

LEPTOSPIRA ANTIBODIES DETECTED IN WILDLIFE IN THE USA AND THE US VIRGIN ISLANDS.

Pedersen K, Anderson TD, Maison RM, Wiscomb GW, Pipas MJ, Sinnett DR, Baroch JA, Gidlewski T.

J Wildl Dis. 2018 Jul;54(3):450-459. doi: 10.7589/2017-10-269. Epub 2018 May 1.

PMID:
29715063
36.

Development and relative validation of a food frequency questionnaire for French-Canadian adolescent and young adult survivors of acute lymphoblastic leukemia.

Morel S, Portolese O, Chertouk Y, Leahy J, Bertout L, Laverdière C, Krajinovic M, Sinnett D, Levy E, Marcil V.

Nutr J. 2018 Apr 21;17(1):45. doi: 10.1186/s12937-018-0355-9.

37.

Insight from mitochondrial functions and proteomics to understand cardiometabolic disorders in survivors of acute lymphoblastic leukemia.

Leahy J, Spahis S, Bonneil E, Garofalo C, Grimard G, Morel S, Laverdière C, Krajinovic M, Drouin S, Delvin E, Sinnett D, Marcil V, Levy E.

Metabolism. 2018 Aug;85:151-160. doi: 10.1016/j.metabol.2018.03.011. Epub 2018 Mar 18.

PMID:
29563052
38.

Vitamin D nutritional status and bone turnover markers in childhood acute lymphoblastic leukemia survivors: A PETALE study.

Delvin E, Alos N, Rauch F, Marcil V, Morel S, Boisvert M, Lecours MA, Laverdière C, Sinnett D, Krajinovic M, Dubois J, Drouin S, Lefebvre G, Samoilenko M, Nyalendo C, Cavalier E, Levy E.

Clin Nutr. 2019 Apr;38(2):912-919. doi: 10.1016/j.clnu.2018.02.006. Epub 2018 Feb 21.

PMID:
29503055
39.

Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy.

Spinella JF, Richer C, Cassart P, Ouimet M, Healy J, Sinnett D.

Blood Adv. 2018 Feb 13;2(3):177-188. doi: 10.1182/bloodadvances.2017011510.

40.

Research- and Practice-Based Nutrition Education and Cooking Workshops in Pediatric Oncology: Protocol for Implementation and Development of Curriculum.

Chaput C, Beaulieu-Gagnon S, Bélanger V, Drouin S, Bertout L, Lafrance L, Olivier C, Robitaille M, Laverdière C, Sinnett D, Marquis M, Marcil V.

JMIR Res Protoc. 2018 Jan 9;7(1):e2. doi: 10.2196/resprot.8302.

41.

Influence of BCL2L11 polymorphism on osteonecrosis during treatment of childhood acute lymphoblastic leukemia.

Plesa M, Gagné V, Glisovic S, Younan M, Sharif-Askari B, Laverdière C, Alos N, Leclerc JM, Sallan SE, Neuberg D, Kutok JL, Silverman LB, Sinnett D, Krajinovic M.

Pharmacogenomics J. 2019 Feb;19(1):33-41. doi: 10.1038/s41397-017-0002-4. Epub 2017 Dec 27.

PMID:
29282361
42.

Cardiometabolic Risk Factors in Childhood, Adolescent and Young Adult Survivors of Acute Lymphoblastic Leukemia - A Petale Cohort.

Levy E, Samoilenko M, Morel S, England J, Amre D, Bertout L, Drouin S, Laverdière C, Krajinovic M, Sinnett D, Lefebvre G, Marcil V.

Sci Rep. 2017 Dec 15;7(1):17684. doi: 10.1038/s41598-017-17716-0.

43.

Tracking Silent Hypersensitivity Reactions to Asparaginase during Leukemia Therapy Using Single-Chip Indirect Plasmonic and Fluorescence Immunosensing.

Charbonneau DM, Breault-Turcot J, Sinnett D, Krajinovic M, Leclerc JM, Masson JF, Pelletier JN.

ACS Sens. 2017 Dec 22;2(12):1761-1766. doi: 10.1021/acssensors.7b00584. Epub 2017 Dec 4.

PMID:
29168384
44.

Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.

England J, Drouin S, Beaulieu P, St-Onge P, Krajinovic M, Laverdière C, Levy E, Marcil V, Sinnett D.

BMC Cancer. 2017 Nov 10;17(1):751. doi: 10.1186/s12885-017-3722-6.

45.

LncRNAs downregulated in childhood acute lymphoblastic leukemia modulate apoptosis, cell migration, and DNA damage response.

Gioia R, Drouin S, Ouimet M, Caron M, St-Onge P, Richer C, Sinnett D.

Oncotarget. 2017 Sep 11;8(46):80645-80650. doi: 10.18632/oncotarget.20817. eCollection 2017 Oct 6.

46.

Spontaneous brain oscillations as neural fingerprints of working memory capacities: A resting-state MEG study.

Oswald V, Zerouali Y, Boulet-Craig A, Krajinovic M, Laverdière C, Sinnett D, Jolicoeur P, Lippé S, Jerbi K, Robaey P.

Cortex. 2017 Dec;97:109-124. doi: 10.1016/j.cortex.2017.09.021. Epub 2017 Oct 3.

PMID:
29102813
47.

Could we use parent report as a valid proxy of child report on anxiety, depression, and distress? A systematic investigation of father-mother-child triads in children successfully treated for leukemia.

Abate C, Lippé S, Bertout L, Drouin S, Krajinovic M, Rondeau É, Sinnett D, Laverdière C, Sultan S.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26840. Epub 2017 Oct 19.

PMID:
29049860
48.

How to interpret high levels of distress when using the Distress Thermometer in the long-term follow-up clinic? A study with Acute Lymphoblastic Leukemia survivors.

Pépin AJ, Lippé S, Krajinovic M, Laverdière C, Michon B, Sinnett D, Sultan S.

Pediatr Hematol Oncol. 2017 Apr;34(3):133-137. doi: 10.1080/08880018.2017.1338805. Epub 2017 Sep 18.

PMID:
28922050
49.

Characterization of the microDNA through the response to chemotherapeutics in lymphoblastoid cell lines.

Mehanna P, Gagné V, Lajoie M, Spinella JF, St-Onge P, Sinnett D, Brukner I, Krajinovic M.

PLoS One. 2017 Sep 6;12(9):e0184365. doi: 10.1371/journal.pone.0184365. eCollection 2017.

50.

Novel therapy for childhood acute lymphoblastic leukemia.

Santiago R, Vairy S, Sinnett D, Krajinovic M, Bittencourt H.

Expert Opin Pharmacother. 2017 Aug;18(11):1081-1099. doi: 10.1080/14656566.2017.1340938. Epub 2017 Jun 26. Review.

PMID:
28608730

Supplemental Content

Loading ...
Support Center